HYDROQUINONE by Obagi Cosmeceuticals LLC

1,310 FDA adverse event reports

About HYDROQUINONE from Obagi Cosmeceuticals LLC

HYDROQUINONE is manufactured by Obagi Cosmeceuticals LLC and is tracked in the FDA Adverse Event Reporting System (FAERS). There are 1,310 adverse event reports for HYDROQUINONE in the FDA database.

This page focuses specifically on HYDROQUINONE as manufactured by Obagi Cosmeceuticals LLC, providing safety context within the manufacturer's broader drug portfolio. Different manufacturers of the same active ingredient may have different adverse event profiles due to variations in formulation, inactive ingredients, manufacturing processes, and patient populations.

Top Adverse Reactions

The following adverse reactions have been most frequently reported for HYDROQUINONE manufactured by Obagi Cosmeceuticals LLC:

SQUAMOUS CELL CARCINOMA OF SKIN44 reports
FATIGUE43 reports
DRUG INEFFECTIVE42 reports
PAIN41 reports
PRURITUS35 reports
PRODUCT USE IN UNAPPROVED INDICATION34 reports
OFF LABEL USE32 reports
CONDITION AGGRAVATED31 reports
ANXIETY30 reports
ARTHRALGIA27 reports
DIARRHOEA27 reports
RASH27 reports
CHRONIC KIDNEY DISEASE25 reports
NAUSEA23 reports
SKIN ATROPHY22 reports
DIZZINESS20 reports
DYSPNOEA19 reports
HEADACHE19 reports
INSOMNIA19 reports
PAIN IN EXTREMITY19 reports
ALOPECIA18 reports
EMOTIONAL DISTRESS18 reports
ASTHENIA16 reports
BACK PAIN16 reports
VOMITING16 reports
CONSTIPATION15 reports
DRY SKIN15 reports
ERYTHEMA15 reports
ACNE14 reports
NEOPLASM SKIN14 reports
PYREXIA14 reports
MUSCLE SPASMS13 reports
SKIN DISCOLOURATION13 reports
ABDOMINAL PAIN12 reports
CHEST PAIN12 reports
SKIN EXFOLIATION12 reports
APPLICATION SITE PAIN11 reports
COUGH11 reports
DEEP VEIN THROMBOSIS11 reports
FALL11 reports
MYALGIA11 reports
OCHRONOSIS11 reports
RENAL FAILURE11 reports
WEIGHT DECREASED11 reports
BLOOD PRESSURE INCREASED10 reports
INJECTION SITE PAIN10 reports
MEMORY IMPAIRMENT10 reports
PULMONARY EMBOLISM10 reports
WEIGHT INCREASED10 reports
ABDOMINAL PAIN UPPER9 reports
DEPRESSION9 reports
HYPERTENSION9 reports
NASOPHARYNGITIS9 reports
PERIPHERAL SWELLING9 reports
PRODUCT DOSE OMISSION ISSUE9 reports
SKIN BURNING SENSATION9 reports
URTICARIA9 reports
ACUTE KIDNEY INJURY8 reports
ANAEMIA8 reports
ANHEDONIA8 reports
BURNING SENSATION8 reports
CONTUSION8 reports
ECZEMA8 reports
INCORRECT DRUG ADMINISTRATION DURATION8 reports
OROPHARYNGEAL PAIN8 reports
RHEUMATOID ARTHRITIS8 reports
SINUSITIS8 reports
SWELLING FACE8 reports
ABDOMINAL DISTENSION7 reports
COVID 197 reports
GAIT DISTURBANCE7 reports
INJURY7 reports
MALAISE7 reports
MIGRAINE7 reports
SWELLING7 reports
THERAPY INTERRUPTED7 reports
ARTHRITIS6 reports
BONE DENSITY DECREASED6 reports
CELLULITIS6 reports
CHEST DISCOMFORT6 reports
DECREASED APPETITE6 reports
DISCOMFORT6 reports
DRUG HYPERSENSITIVITY6 reports
DRY EYE6 reports
ECONOMIC PROBLEM6 reports
END STAGE RENAL DISEASE6 reports
EYE SWELLING6 reports
GASTROOESOPHAGEAL REFLUX DISEASE6 reports
HAIR TEXTURE ABNORMAL6 reports
HYPERSENSITIVITY6 reports
ILLNESS6 reports
INTENTIONAL PRODUCT USE ISSUE6 reports
MUSCULOSKELETAL CHEST PAIN6 reports
NEUROPATHY PERIPHERAL6 reports
PIGMENTATION DISORDER6 reports
PSORIASIS6 reports
RASH ERYTHEMATOUS6 reports
SKIN HYPERPIGMENTATION6 reports
SKIN IRRITATION6 reports
SOMNOLENCE6 reports

Report Outcomes

Out of 559 classified reports for HYDROQUINONE:

  • Serious: 318 reports (56.9%)
  • Non-Serious: 241 reports (43.1%)

Frequently Asked Questions

What are the side effects of HYDROQUINONE?

The most commonly reported side effects of HYDROQUINONE include SQUAMOUS CELL CARCINOMA OF SKIN, FATIGUE, DRUG INEFFECTIVE. These are based on 1,310 FDA adverse event reports.

Is HYDROQUINONE manufactured by Obagi Cosmeceuticals LLC safe?

HYDROQUINONE has a safety score of N/A based on AI analysis of FDA adverse event reports. Always discuss medication risks with your healthcare provider.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.